14Dec
Financial Daily Dose 12.14.2020 | Top Story: AstraZeneca Acquires Alexion in $39 Billion Push into Immunology
Drugmaker AstraZeneca agreed on Saturday to buy biopharma company Alexion for $39 billion in cash and stock. In the deal—the “biggest by a health care company this year”—will help AstraZeneca expand into the immunology sector....
By:
Robins Kaplan LLP
Related
Our quarterly report discusses new developments in class action litigation and offers strategic guid...
Read More >
Dear YouDig? Freedom? The laws of construction sure don’t provide “Freedom.” It’s more like law...
Read More >
U.S. government officials and cybersecurity experts are warning businesses to prepare for a surge in...
Read More >
Recently, the Legislature passed and the Governor signed two Public Acts that made significant chang...
Read More >
In a unanimous decision late last week, the 9th Circuit Court of Appeals resuscitated class claims a...
Read More >
On November 12, 2020, President Trump issued an Executive Order titled "Addressing the Threat from S...
Read More >